People with germline likely pathogenic/pathogenic (LP/P) BRCA1/2 variants are at an increased risk of various cancers, including breast, ovarian, pancreatic, and prostate cancers [2, 3]. This evidence concerns the gene BRCA1 and prostate carcinoma.